These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21340088)

  • 1. Microarray-based target identification using drug hypersensitive fission yeast expressing ORFeome.
    Arita Y; Nishimura S; Matsuyama A; Yashiroda Y; Usui T; Boone C; Yoshida M
    Mol Biosyst; 2011 May; 7(5):1463-72. PubMed ID: 21340088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.
    Barker KS; Pearson MM; Rogers PD
    J Antimicrob Chemother; 2003 May; 51(5):1131-40. PubMed ID: 12697649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe.
    Matsuyama A; Arai R; Yashiroda Y; Shirai A; Kamata A; Sekido S; Kobayashi Y; Hashimoto A; Hamamoto M; Hiraoka Y; Horinouchi S; Yoshida M
    Nat Biotechnol; 2006 Jul; 24(7):841-7. PubMed ID: 16823372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA microarray for fission yeast: minimal changes in global gene expression after temperature shift.
    Xue Y; Haas SA; Brino L; Gusnanto A; Reimers M; Talibi D; Vingron M; Ekwall K; Wright AP
    Yeast; 2004 Jan; 21(1):25-39. PubMed ID: 14745780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3' ends of mature transcripts are generated by a processosome complex in fission yeast mitochondria.
    Hoffmann B; Nickel J; Speer F; Schafer B
    J Mol Biol; 2008 Apr; 377(4):1024-37. PubMed ID: 18304578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Candida albicans growth by brominated furanones.
    Duo M; Zhang M; Luk YY; Ren D
    Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomewide identification of pheromone-targeted transcription in fission yeast.
    Xue-Franzén Y; Kjaerulff S; Holmberg C; Wright A; Nielsen O
    BMC Genomics; 2006 Nov; 7():303. PubMed ID: 17137508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced phenotypes provide a tool for the functional analysis of yeast genes.
    Launhardt H; Hinnen A; Munder T
    Yeast; 1998 Jul; 14(10):935-42. PubMed ID: 9717239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway.
    Butcher RA; Bhullar BS; Perlstein EO; Marsischky G; LaBaer J; Schreiber SL
    Nat Chem Biol; 2006 Feb; 2(2):103-9. PubMed ID: 16415861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide identification of haploinsufficiency in fission yeast.
    Baek ST; Han S; Nam M; Kim YD; Kim L; Lee HJ; Heo KS; Lee H; Lee M; Park SK; Maeng PJ; Park Y; Lee S; Kim DU; Kim D; Hoe KL
    J Microbiol Biotechnol; 2008 Jun; 18(6):1059-63. PubMed ID: 18600047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug target validation and identification of secondary drug target effects using DNA microarrays].
    Owa T
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1808-9. PubMed ID: 18051436
    [No Abstract]   [Full Text] [Related]  

  • 17. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2.
    Bruno VM; Mitchell AP
    Mol Microbiol; 2005 Apr; 56(2):559-73. PubMed ID: 15813744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codon usage bias is correlated with gene expression levels in the fission yeast Schizosaccharomyces pombe.
    Hiraoka Y; Kawamata K; Haraguchi T; Chikashige Y
    Genes Cells; 2009 Apr; 14(4):499-509. PubMed ID: 19335619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces pombe.
    Baryshnikova A; Costanzo M; Dixon S; Vizeacoumar FJ; Myers CL; Andrews B; Boone C
    Methods Enzymol; 2010; 470():145-79. PubMed ID: 20946810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.